Silvia Ferrer López

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Silvia Ferrer López

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology

Vall Hebron Institut de Recerca

Related news

Neurofilament monitoring detects multiple sclerosis activity not visible in standard tests

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

Professionals que participen al projecte TACTIC

TACTIC project groups present new advances

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

A questionnaire and self-administered tests detect the progression of multiple sclerosis

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.